Publications by authors named "Phillipe Moreau"

Claim this Profile
E
Exploring the impact of dexamethasone on gene regulation in myeloma cells.
Victor Bessonneau-Gaborit, Jonathan Cruard, Catherine Guerin-Charbonnel, Jennifer Derrien, Jean-Baptiste Alberge, Phillipe Moreau

Life Sci Alliance· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment emergent peripheral neuropathy in the CASSIOPEIA trial.
Cathelijne Fokkema, Phillipe Moreau, Bronno Van der Holt, Jérôme Lambert, Mark Van Duin

Haematologica· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk.
Shambavi Richard, Ajai Chari, Sosana Delimpasi, Maryana Simonova, Ivan Spicka, Phillipe Moreau

Am J Hematol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma.
Holger W Auner, Maria Gavriatopoulou, Sosana Delimpasi, Maryana Simonova, Ivan Spicka, Phillipe Moreau

Am J Hematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial.
Sebastian Grosicki, Maryana Simonova, Ivan Spicka, Ludek Pour, Iryrna Kriachok, Phillipe Moreau

Lancet· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis.
Brian A Walker, Konstantinos Mavrommatis, Christopher P Wardell, T Cody Ashby, Michael Bauer, Phillipe Moreau

Leukemia· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection.
Emmanuel Montassier, Gabriel A Al-Ghalith, Tonya Ward, Stephane Corvec, Thomas Gastinne, Phillipe Moreau

Genome Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.
Sergio Giralt, Laurent Garderet, Brian Durie, Gordon Cook, Gosta Gahrton, Phillipe Moreau

Biol Blood Marrow Transplant· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial treatment of transplant-eligible patients in multiple myeloma.
Laura Rosiñol, Shaji Kumar, Phillipe Moreau, Michele Cavo

Expert Rev Hematol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis